Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06288867
Status:
RECRUITING
Last Update Posted:
2024-03-18
First Post:
2024-02-24
Brief Title:
A 12 Months Prospective Study Comparing Functional Outcome Scores in Hip Arthroscopic Labral Repair Versus Debridement
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
Arthroscopic Labral Repair Versus Debridement In Hip Labral Tears A Prospective Comparative Study
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to address hip labral tears and compare between arthroscopic labral repair versus debridement
Detailed Description:
Hip arthroscopy will be performed with the patient under general anesthesia The patient will be placed in supine position and traction and joint access will be controlled by fluoroscopy An anterolateral portal and an inferior mid-anterior portal will be used Any labral chondral andor bony pathology cam or pincer will be treated Labral tears may be debrided or repaired Labral repairs will be secured with suture anchors
Patients functions will be evaluated preoperatively and postoperatively at 1 3 and 6 months and 1 year and at the last follow-up using the Harris Hip Score HHS visual analog score VAS Hip Outcome Score Activities-Daily Living Subscale HOS-ADL and Sport-Specific Subscale HOS-SSS
Patients functions will be evaluated preoperatively and postoperatively at 1 3 and 6 months and 1 year and at the last follow-up using the Harris Hip Score HHS visual analog score VAS Hip Outcome Score Activities-Daily Living Subscale HOS-ADL and Sport-Specific Subscale HOS-SSS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None